Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""MESH: T-Lymphocytes/immunology"" wg kryterium: Temat


Tytuł :
Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum
Autorzy :
Michel, Grégory
Ferrua, Bernard
Munro, Patrick
Boyer, Laurent
Mathal, Nassim
Gillet, Daniel
Marty, Pierre
Lemichez, Emmanuel
Pokaż więcej
Temat :
MESH: Administration, Intranasal
Immunoassays
MESH: Immunity, Humoral/immunology
Vaccination and immunization
[SDV.BC]Life Sciences [q-bio]/Cellular Biology
MESH: Mice, Inbred BALB C
Parasitic Protozoans
Public and Occupational Health
Enzyme-linked immunoassays
MESH: Female
Immunology
MESH: Bacterial Toxins/genetics
MESH: Escherichia coli Proteins/genetics
Biology and Life Sciences
Spleen
MESH: T-Lymphocytes/immunology
Physiology
[SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC]
MESH: Interleukin-2/metabolism
Leishmania infantum
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
Immunologic Techniques
MESH: Leishmania infantum/pathogenicity
MESH: Mice
Life Cycles
Science
[SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB]
Organisms
Parasitic diseases
[SDV]Life Sciences [q-bio]
MESH: Animals
Promastigotes
MESH: Leishmania infantum/immunology
Research Article
Leishmania
MESH: Escherichia coli Proteins/metabolism
Preventive Medicine
MESH: Vaccination/methods
MESH: Interleukin-4/metabolism
Protozoans
Protozoan Life Cycles
Immune response
Protozoology
Immune Physiology
Developmental Biology
Research and Analysis Methods
Microbiology
Medicine
MESH: Antigens, Protozoan/immunology
[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology
Medicine and Health Sciences
MESH: Immunity, Humoral/physiology
MESH: Bacterial Toxins/metabolism
Źródło :
PLoS ONE, Public Library of Science, 2016, 11 (6), pp.e0156363. ⟨10.1371/journal.pone.0156363⟩
PLoS ONE, Vol 11, Iss 6, p e0156363 (2016)
Tytuł :
Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection
Autorzy :
Sultanik, S.
Casrouge, A.
Alanio, C.
Mottez, E.
Hézode, I.
Hézode, C.
Renard, P.
Bousquet, L.
Pellet, P.
Uzé, G.
Pol, S.
Albert, M. L.
Mallet, V.
Pokaż więcej
Temat :
MESH: Viral Load
MESH: Drug Therapy, Combination
MESH: Male
MESH: Treatment Outcome
MESH: Aged
[SDV.IMM]Life Sciences [q-bio]/Immunology
MESH: T-Lymphocytes/immunology
MESH: Phosphorylation
chronic HCV infection
MESH: Hepatitis C, Chronic/immunology
MESH: Drug Resistance/genetics
MESH: Female
MESH: Leukocytes, Mononuclear/immunology
MESH: Interferon-alpha/pharmacology
[SDV.IMM] Life Sciences [q-bio]/Immunology
MESH: Hepatitis C, Chronic/drug therapy
MESH: Hepatitis C, Chronic/genetics
MESH: T-Lymphocytes/drug effects
MESH: Hepatitis C, Chronic/virology
MESH: Humans
IFNα desensitization
MESH: Case-Control Studies
MESH: STAT1 Transcription Factor/metabolism
T cells
MESH: Antiviral Agents/pharmacology
MESH: Antiviral Agents/therapeutic use
MESH: Polymorphism, Single Nucleotide
MESH: Middle Aged
MESH: Leukocytes, Mononuclear/drug effects
MESH: Leukocytes, Mononuclear/metabolism
MESH: Interferon-alpha/therapeutic use
MESH: T-Lymphocytes/metabolism
IFN-based triple therapy
MESH: Interleukins/genetics
Źródło :
Journal of Viral Hepatitis, Wiley-Blackwell, 2015, 22 (6), pp.524 - 534. 〈10.1111/jvh.12355〉
Journal of Viral Hepatitis, Wiley-Blackwell, 2015, 22 (6), pp.524 - 534. ⟨10.1111/jvh.12355⟩
Journal of Viral Hepatitis
Tytuł :
Effect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells
Autorzy :
Mrizak, Dhafer
Martin, Nathalie
Barjon, Clément
Jimenez-Pailhes, Anne-Sophie
Mustapha, Rami
Niki, Toshiro
Guigay, Joël
Pancré, Véronique
de Launoit, Yvan
Busson, Pierre
Moralès, Olivier
Delhem, Nadira
Pokaż więcej
Temat :
MESH: Animals
MESH: Nasopharyngeal Neoplasms/metabolism
MESH: CD4-Positive T-Lymphocytes/immunology
otorhinolaryngologic diseases
regulatory
MESH: Real-Time Polymerase Chain Reaction
MESH: Gene Expression Regulation, Neoplastic
MESH: Transforming Growth Factor beta1/immunology
MESH: CD4-Positive T-Lymphocytes/metabolism
MESH: T-Lymphocytes, Regulatory/immunology
MESH: Blotting, Western
exosomes
MESH: T-Lymphocytes, Regulatory/metabolism
MESH: Exosomes/immunology
hemic and immune systems
MESH: Interleukin-2 Receptor alpha Subunit/metabolism
MESH: Mice, SCID
phenotype
MESH: Heterografts
antigens/cd25
MESH: T-Lymphocytes/immunology
MESH: Humans
MESH: Interleukin-10/immunology
MESH: Forkhead Transcription Factors/metabolism
MESH: Chemokine CCL20/metabolism
MESH: Flow Cytometry
MESH: Exosomes/metabolism
MESH: Nasopharyngeal Neoplasms/immunology
MESH: Mice
MESH: Cell Proliferation
t-lymphocytes
chemical and pharmacologic phenomena
MESH: Carcinoma/immunology
MESH: Carcinoma/metabolism
[SDV]Life Sciences [q-bio]
MESH: T-Lymphocytes/metabolism
stomatognathic diseases
neoplasms
MESH: Cell Line, Tumor
Źródło :
JNCI: Journal of the National Cancer Institute, Oxford University Press (OUP), 2015, 107 (1), pp.363. ⟨10.1093/jnci/dju363⟩
JNCI: Journal of the National Cancer Institute
Tytuł :
Targeted Delivery of α-Galactosylceramide to CD8α + Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
Autorzy :
Macho-Fernandez, Elodie
Cruz, Luis Javier
Ghinnagow, Reem
Fontaine, Josette
Bialecki, Emilie
Frisch, Benoît
Trottein, François
Faveeuw, Christelle
Pokaż więcej
Temat :
MESH: Animals
MESH: Antibodies/chemistry
MESH: Dendritic Cells/immunology
MESH: Dendritic Cells/metabolism
MESH: Drug Delivery Systems/methods
MESH: Galactosylceramides/administration & dosage
MESH: Galactosylceramides/chemistry
MESH: Galactosylceramides/immunology
MESH: Lectins, C-Type/immunology
MESH: Lymphocyte Activation/immunology
MESH: Male
MESH: Mice
MESH: Antibodies/immunology
MESH: Mice, Inbred C57BL
MESH: Mice, Knockout
MESH: Mice, Transgenic
MESH: Minor Histocompatibility Antigens
MESH: Nanoparticles/administration & dosage
MESH: Nanoparticles/chemistry
MESH: Natural Killer T-Cells/immunology
MESH: Natural Killer T-Cells/metabolism
MESH: Neoplasms, Experimental/immunology
MESH: Neoplasms, Experimental/pathology
MESH: Antigen Presentation/immunology
MESH: Neoplasms, Experimental/therapy
MESH: Receptors, Antigen, T-Cell, gamma-delta/immunology
MESH: Receptors, Antigen, T-Cell, gamma-delta/metabolism
MESH: Receptors, Cell Surface/immunology
MESH: T-Lymphocytes/immunology
MESH: T-Lymphocytes/metabolism
MESH: T-Lymphocytes, Cytotoxic/immunology
MESH: T-Lymphocytes, Cytotoxic/metabolism
MESH: Tumor Burden/immunology
MESH: Antigens, CD/immunology
MESH: CD8 Antigens/immunology
MESH: CD8 Antigens/metabolism
MESH: CD8-Positive T-Lymphocytes/immunology
MESH: CD8-Positive T-Lymphocytes/metabolism
MESH: Cell Line, Tumor
[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity
Źródło :
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Tytuł :
Targeted Delivery of α-Galactosylceramide to CD8α + Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
Autorzy :
Macho-Fernandez, Elodie
Cruz, Luis Javier
Ghinnagow, Reem
Fontaine, Josette
Bialecki, Emilie
Frisch, Benoît
Trottein, François
Faveeuw, Christelle
Pokaż więcej
Temat :
MESH: Animals
MESH: Antibodies/chemistry
MESH: Dendritic Cells/immunology
MESH: Dendritic Cells/metabolism
MESH: Drug Delivery Systems/methods
MESH: Galactosylceramides/administration & dosage
MESH: Galactosylceramides/chemistry
MESH: Galactosylceramides/immunology
MESH: Lectins, C-Type/immunology
MESH: Lymphocyte Activation/immunology
MESH: Male
MESH: Mice
MESH: Antibodies/immunology
MESH: Mice, Inbred C57BL
MESH: Mice, Knockout
MESH: Mice, Transgenic
MESH: Minor Histocompatibility Antigens
MESH: Nanoparticles/administration & dosage
MESH: Nanoparticles/chemistry
MESH: Natural Killer T-Cells/immunology
MESH: Natural Killer T-Cells/metabolism
MESH: Neoplasms, Experimental/immunology
MESH: Neoplasms, Experimental/pathology
MESH: Antigen Presentation/immunology
MESH: Neoplasms, Experimental/therapy
MESH: Receptors, Antigen, T-Cell, gamma-delta/immunology
MESH: Receptors, Antigen, T-Cell, gamma-delta/metabolism
MESH: Receptors, Cell Surface/immunology
MESH: T-Lymphocytes/immunology
MESH: T-Lymphocytes/metabolism
MESH: T-Lymphocytes, Cytotoxic/immunology
MESH: T-Lymphocytes, Cytotoxic/metabolism
MESH: Tumor Burden/immunology
MESH: Antigens, CD/immunology
MESH: CD8 Antigens/immunology
MESH: CD8 Antigens/metabolism
MESH: CD8-Positive T-Lymphocytes/immunology
MESH: CD8-Positive T-Lymphocytes/metabolism
MESH: Cell Line, Tumor
[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity
Źródło :
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Tytuł :
Targeted Delivery of α-Galactosylceramide to CD8α + Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
Autorzy :
Macho-Fernandez, Elodie
Cruz, Luis Javier
Ghinnagow, Reem
Fontaine, Josette
Bialecki, Emilie
Frisch, Benoît
Trottein, François
Faveeuw, Christelle
Pokaż więcej
Temat :
MESH: Dendritic Cells/metabolism
MESH: Animals
MESH: Mice, Transgenic
MESH: Male
MESH: Receptors, Antigen, T-Cell, gamma-delta/metabolism
MESH: Galactosylceramides/chemistry
MESH: Nanoparticles/administration & dosage
MESH: CD8 Antigens/immunology
MESH: Drug Delivery Systems/methods
MESH: Receptors, Antigen, T-Cell, gamma-delta/immunology
MESH: Galactosylceramides/immunology
MESH: T-Lymphocytes, Cytotoxic/immunology
MESH: Mice, Inbred C57BL
MESH: Neoplasms, Experimental/pathology
MESH: CD8-Positive T-Lymphocytes/metabolism
MESH: Receptors, Cell Surface/immunology
MESH: Antibodies/chemistry
MESH: Natural Killer T-Cells/metabolism
MESH: Tumor Burden/immunology
MESH: Neoplasms, Experimental/therapy
MESH: Antigens, CD/immunology
MESH: Dendritic Cells/immunology
[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity
MESH: T-Lymphocytes/immunology
MESH: Galactosylceramides/administration & dosage
MESH: Neoplasms, Experimental/immunology
MESH: Mice
MESH: Lectins, C-Type/immunology
chemical and pharmacologic phenomena
MESH: Mice, Knockout
MESH: Lymphocyte Activation/immunology
MESH: CD8 Antigens/metabolism
MESH: Nanoparticles/chemistry
MESH: T-Lymphocytes/metabolism
MESH: Minor Histocompatibility Antigens
MESH: Antigen Presentation/immunology
MESH: T-Lymphocytes, Cytotoxic/metabolism
MESH: Antibodies/immunology
MESH: Natural Killer T-Cells/immunology
MESH: CD8-Positive T-Lymphocytes/immunology
MESH: Cell Line, Tumor
Źródło :
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies